Company intelligence / Profile preview

Laboratoires Genevrier

Antibes/Sophia-Antipolis, Alpes-Maritimes, Francelaboratoires-genevrier.com ↗

Ownership: Private
Employees: ~221
Development stage: Commercial

Overview

Laboratoires Genevrier has a broad commercial portfolio including pharmaceuticals across several therapeutic areas and medical devices such as Viticell®, which enables autologous cell suspension for skin repigmentation. The company also markets cosmetic and dermocosmetic products like the ialugen® range. No specific recent clinical trial results are publicly highlighted; most products are already marketed or CE-marked medical devices.

Therapeutic areas: EndocrinologyOtherDermatologyRheumatologyWomen's Health
Modalities: Medical devicesCosmeticsDermatology productsPharmaceuticals
Industry: Biotech

Drug pipeline

1 asset

Ialuset

Unknown

Partnerships

Distributor for IBSA Group (historically, before acquisition)

Beyond the preview

Go deeper on Laboratoires Genevrier.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Laboratoires Genevrier.

Explore the full profile